YGIX MEDICINES
LIVE

Serial Number

99240832

Owner

YGIX Medicines Limited

Attorney

John J. O'Malley

Filing Date

Jun 18, 2025

Add to watchlist:

No watchlists yet
View on USPTO

YGIX MEDICINES Trademark

Serial Number: 99240832

YGIX MEDICINES is a trademark filed by YGIX Medicines Limited on June 18, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently pending registration.

Owner Contact Info

YGIX Medicines Limited (2 trademarks)

Shankill Business Centre, Station House
Shankill, Dublin D18 N1N2 , IE

Entity Type: 99

Trademark Details

Filing Date

June 18, 2025

Registration Date

Not Registered

Published for Opposition

March 17, 2026

Goods & Services

(Based on 44(d) Priority Application) Pharmaceutical research services; Pharmaceutical product evaluation; Research of pharmaceuticals; Pharmaceutical research and development; Research relating to pharmaceuticals; Pharmaceutical research and development services; Research on the subject of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Research and development for the pharmaceutical industry; Consultancy in the field of pharmaceutical research; Consultancy relating to pharmaceutical research and development; Laboratory research in the field of pharmaceuticals; Technical research in the field of pharmaceutical studies; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical products development; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines; Preparation of scientific research reports in the biotechnology field; Consultancy in the field of biotechnology; Consultancy relating to biotechnology; Biotechnology testing services; Biotechnology research; Research relating to biotechnology; Scientific consultancy services relating to pharmaceutical and biotechnology research and development; Scientific analysis services in the field of pharmaceuticals and biotechnology; Scientific services, namely, scientific laboratory services, scientific research and analysis services in the field of pharmaceuticals and biotechnology; Scientific research; Scientific testing services, namely, testing of pharmaceuticals for scientific research purposes; Scientific research services; Scientific advisory services relating to pharmaceutical and biotechnology development; Scientific research consulting; Scientific laboratory services (Based on Intent to Use) Veterinary research; Veterinary laboratory services being veterinary research laboratories

(Based on 44(d) Priority Application) Pharmaceutical preparations for the treatment of oncological, hematological, immunological, neurological, cardiovascular, metabolic, infectious, inflammatory, dermatological, gastrointestinal, hepatic, respiratory, renal, ophthalmic, and musculoskeletal diseases and disorders in humans (Based on Intent to Use) Veterinary pharmaceutical preparations for the treatment of oncological, hematological, immunological, neurological, cardiovascular, metabolic, infectious, inflammatory, dermatological, gastrointestinal, hepatic, respiratory, renal, ophthalmic, and musculoskeletal diseases and disorders in animals

(Based on 44(d) Priority Application) Pharmaceutical consultation; Pharmaceutical advice; Pharmaceutical advisory services; Provision of pharmaceutical information; Medical consultancy and information services relating to pharmaceutical products (Based on Intent to Use) Veterinary advisory services; Providing veterinary information; Information services relating to veterinary pharmaceuticals; Veterinary laboratory services in the nature of veterinary analysis services for diagnostic and treatment purposes provided by veterinary laboratories

Intellectual property consultation; Intellectual property consultancy; Protection of intellectual property, namely, intellectual property licensing services and intellectual property rights management; Intellectual property services, namely, intellectual property consultancy services and intellectual property licensing services; Intellectual property licensing services; Management of intellectual property; Licensing of intellectual property; Licensing of intellectual property rights; Consultancy relating to intellectual property management; Intellectual property management services; Advisory services relating to intellectual property rights; Consultancy relating to the licensing of intellectual property; Intellectual property consultancy services for universities and research institutions

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 12, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 18, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 12, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 12, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 12, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 12, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 6, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 25, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 18, 2025 MAFR
NEW APPLICATION ENTERED
Jun 18, 2025 NWAP